Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Mangalam Drugs & Organics Revenue

Mangalam Drugs & Organics had revenue of 571.19M INR in the quarter ending June 30, 2026, a decrease of -0.16%. This brings the company's revenue in the last twelve months to 2.32B, down -22.21% year-over-year. In the fiscal year ending March 31, 2026, Mangalam Drugs & Organics had annual revenue of 2.32B, down -26.90%.

• Revenue (ttm): 2.32B
• Revenue Growth: -22.21%
• P/S Ratio: 0.22
• Revenue / Employee: 7.27M
• Employees: 319
• Market Cap: 511.41M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.32B	-854.43M	-26.90%
Mar 31, 2025	3.18B	-497.78M	-13.55%
Mar 31, 2024	3.67B	-28.42M	-0.77%
Mar 31, 2023	3.70B	-806.66M	-17.89%
Mar 31, 2022	4.51B	708.84M	18.65%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 23, 2026

Data Sources Report a data error